6OAG
Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02-82
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | CLSI BEAMLINE 08ID-1 |
| Synchrotron site | CLSI |
| Beamline | 08ID-1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2019-02-25 |
| Detector | DECTRIS PILATUS3 S 6M |
| Wavelength(s) | 0.97949 |
| Spacegroup name | P 41 21 2 |
| Unit cell lengths | 111.350, 111.350, 76.860 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 55.740 - 2.300 |
| R-factor | 0.19569 |
| Rwork | 0.193 |
| R-free | 0.24145 |
| Structure solution method | FOURIER SYNTHESIS |
| Starting model (for MR) | 4xqr |
| RMSD bond length | 0.018 |
| RMSD bond angle | 1.685 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | REFMAC (5.8.0238) |
| Refinement software | REFMAC (5.8.0238) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 76.860 | 2.340 |
| High resolution limit [Å] | 2.300 | 2.300 |
| Rmerge | 0.067 | 1.631 |
| Rmeas | 0.069 | 1.707 |
| Rpim | 0.020 | 0.496 |
| Number of reflections | 21951 | 1069 |
| <I/σ(I)> | 18.8 | 1.7 |
| Completeness [%] | 99.6 | 97.3 |
| Redundancy | 12.7 | 11.5 |
| CC(1/2) | 1.000 | 0.797 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 7.5 | 295 | 0.075 M HEPES, 0.6 M potassium phosphate, 0.6 M sodium phosphate, 25% glycerol |






